Marcella Occelli

Cuneo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.

Journal: Tumori

Published: October 18, 2025

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: September 21, 2025

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 02, 2023

Patients with cancer and hospital admissions: disease trajectory and strategic choices.

Patients with cancer and hospital admissions: disease trajectory and strategic choices.

Journal: BMJ supportive & palliative care

Published: August 25, 2023

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.

Journal: Cancers

Published: May 12, 2023

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 28, 2022

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review.

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review.

Journal: Biomedicines

Published: June 08, 2022

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.

Journal: Journal of translational medicine

Published: January 03, 2022

Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review.

Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review.

Journal: European journal of case reports in internal medicine

Published: May 13, 2021

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience.

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience.

Journal: Frontiers in oncology

Published: March 04, 2021

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study.

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study.

Journal: ESMO open

Published: December 15, 2020

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study.

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study.

Journal: Cancers

Published: December 04, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026